Cargando…
FRI307 Gigantism Due To Transcriptional Activation Of GHRH: The First Case Of Hormone-encoding Gene Overexpression Underlying A Congenital Disorder
Disclosure: A. Hattori: None. Y. Katoh-Fukui: None. R. Zhang: None. M. Terao: None. S. Takada: None. K. Nakabayashi: None. K. Hata: None. Y. Yamada: None. N. Matsuura: None. M. Fukami: None. Background: Pituitary gigantism is characterized by tall stature due to GH overproduction. To date, known gen...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555338/ http://dx.doi.org/10.1210/jendso/bvad114.1242 |
_version_ | 1785116633057984512 |
---|---|
author | Hattori, Atsushi Katoh-Fukui, Yuko Zhang, Ruogu Terao, Miho Takada, Shuji Nakabayashi, Kazuhiko Hata, Kenichiro Yamada, Yutaka Matsuura, Nobuo Fukami, Maki |
author_facet | Hattori, Atsushi Katoh-Fukui, Yuko Zhang, Ruogu Terao, Miho Takada, Shuji Nakabayashi, Kazuhiko Hata, Kenichiro Yamada, Yutaka Matsuura, Nobuo Fukami, Maki |
author_sort | Hattori, Atsushi |
collection | PubMed |
description | Disclosure: A. Hattori: None. Y. Katoh-Fukui: None. R. Zhang: None. M. Terao: None. S. Takada: None. K. Nakabayashi: None. K. Hata: None. Y. Yamada: None. N. Matsuura: None. M. Fukami: None. Background: Pituitary gigantism is characterized by tall stature due to GH overproduction. To date, known genetic causes of pituitary gigantism are invariably associated with predispositions to tumors producing GH or GHRH. Clinical and genetic findings of the patient: The patient was a Japanese woman who was born mildly large for gestational age. Her overgrowth started in her first year of life. Despite radiation and pharmacotherapy starting at age three years, she reached an adult height of 197 cm (+7.4 SD). She developed panhypopituitarism associated with empty sella in adulthood and was deceased during sleep at age 53 years. Exome sequencing identified no pathogenic variant causing acromegaly or gigantism. Chromosomal microarray analysis detected a 752-kb deletion upstream of GHRH. This deletion was predicted to create a chimeric gene consisting of the 5´-UTR of TTI1, a ubiquitously expressed gene, and the coding region of GHRH. Reverse transcription PCR (RT-PCR) using mRNA of immortalized lymphoblastoid cells detected the chimeric transcript. Analysis of model mice: We established a mouse model harboring a 676-kb deletion upstream of Ghrh using the CRISPR/Cas9 system. RT-PCR detected a chimeric transcript consisting of the 5´-UTR of Tti1 and the coding region of Ghrh, which mimicked the patient’s chimeric transcript. Mutant mice started to overgrow at two weeks of age and showed high serum GH levels and long tibia at 12-13 weeks of age. Quantitative RT-PCR showed that the median level of Ghrh expression in the hypothalamus of the mutant mice was three-fold higher than that of the wildtype mice. Furthermore, the mutant mice had ectopic Ghrh expression in all analyzed tissues (the pituitary, thymus, heart, liver, and gonad). Discussion: Our findings propose a novel etiology of gigantism. In the present case, the GHRH gene obtained a constitutively active promoter through germline genomic microdeletion. The newly acquired promoter likely led to the constant expression of GHRH in various tissues including the hypothalamus. Possible explanations for GH overproduction in the present case include (1) GHRH overproduction in the hypothalamus, (2) paracrine and autocrine effects of GHRH secreted from the pituitary, and (3) endocrine effects of GHRH produced outside the hypothalamic-pituitary unit. The patient’s clinical course suggests that prenatal GHRH overproduction only mildly affects human growth. More importantly, this is the first case in which transcriptional activation of a hormone-encoding gene caused a human congenital disorder. Presentation: Friday, June 16, 2023 |
format | Online Article Text |
id | pubmed-10555338 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-105553382023-10-06 FRI307 Gigantism Due To Transcriptional Activation Of GHRH: The First Case Of Hormone-encoding Gene Overexpression Underlying A Congenital Disorder Hattori, Atsushi Katoh-Fukui, Yuko Zhang, Ruogu Terao, Miho Takada, Shuji Nakabayashi, Kazuhiko Hata, Kenichiro Yamada, Yutaka Matsuura, Nobuo Fukami, Maki J Endocr Soc Neuroendocrinology & Pituitary Disclosure: A. Hattori: None. Y. Katoh-Fukui: None. R. Zhang: None. M. Terao: None. S. Takada: None. K. Nakabayashi: None. K. Hata: None. Y. Yamada: None. N. Matsuura: None. M. Fukami: None. Background: Pituitary gigantism is characterized by tall stature due to GH overproduction. To date, known genetic causes of pituitary gigantism are invariably associated with predispositions to tumors producing GH or GHRH. Clinical and genetic findings of the patient: The patient was a Japanese woman who was born mildly large for gestational age. Her overgrowth started in her first year of life. Despite radiation and pharmacotherapy starting at age three years, she reached an adult height of 197 cm (+7.4 SD). She developed panhypopituitarism associated with empty sella in adulthood and was deceased during sleep at age 53 years. Exome sequencing identified no pathogenic variant causing acromegaly or gigantism. Chromosomal microarray analysis detected a 752-kb deletion upstream of GHRH. This deletion was predicted to create a chimeric gene consisting of the 5´-UTR of TTI1, a ubiquitously expressed gene, and the coding region of GHRH. Reverse transcription PCR (RT-PCR) using mRNA of immortalized lymphoblastoid cells detected the chimeric transcript. Analysis of model mice: We established a mouse model harboring a 676-kb deletion upstream of Ghrh using the CRISPR/Cas9 system. RT-PCR detected a chimeric transcript consisting of the 5´-UTR of Tti1 and the coding region of Ghrh, which mimicked the patient’s chimeric transcript. Mutant mice started to overgrow at two weeks of age and showed high serum GH levels and long tibia at 12-13 weeks of age. Quantitative RT-PCR showed that the median level of Ghrh expression in the hypothalamus of the mutant mice was three-fold higher than that of the wildtype mice. Furthermore, the mutant mice had ectopic Ghrh expression in all analyzed tissues (the pituitary, thymus, heart, liver, and gonad). Discussion: Our findings propose a novel etiology of gigantism. In the present case, the GHRH gene obtained a constitutively active promoter through germline genomic microdeletion. The newly acquired promoter likely led to the constant expression of GHRH in various tissues including the hypothalamus. Possible explanations for GH overproduction in the present case include (1) GHRH overproduction in the hypothalamus, (2) paracrine and autocrine effects of GHRH secreted from the pituitary, and (3) endocrine effects of GHRH produced outside the hypothalamic-pituitary unit. The patient’s clinical course suggests that prenatal GHRH overproduction only mildly affects human growth. More importantly, this is the first case in which transcriptional activation of a hormone-encoding gene caused a human congenital disorder. Presentation: Friday, June 16, 2023 Oxford University Press 2023-10-05 /pmc/articles/PMC10555338/ http://dx.doi.org/10.1210/jendso/bvad114.1242 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Neuroendocrinology & Pituitary Hattori, Atsushi Katoh-Fukui, Yuko Zhang, Ruogu Terao, Miho Takada, Shuji Nakabayashi, Kazuhiko Hata, Kenichiro Yamada, Yutaka Matsuura, Nobuo Fukami, Maki FRI307 Gigantism Due To Transcriptional Activation Of GHRH: The First Case Of Hormone-encoding Gene Overexpression Underlying A Congenital Disorder |
title | FRI307 Gigantism Due To Transcriptional Activation Of GHRH: The First Case Of Hormone-encoding Gene Overexpression Underlying A Congenital Disorder |
title_full | FRI307 Gigantism Due To Transcriptional Activation Of GHRH: The First Case Of Hormone-encoding Gene Overexpression Underlying A Congenital Disorder |
title_fullStr | FRI307 Gigantism Due To Transcriptional Activation Of GHRH: The First Case Of Hormone-encoding Gene Overexpression Underlying A Congenital Disorder |
title_full_unstemmed | FRI307 Gigantism Due To Transcriptional Activation Of GHRH: The First Case Of Hormone-encoding Gene Overexpression Underlying A Congenital Disorder |
title_short | FRI307 Gigantism Due To Transcriptional Activation Of GHRH: The First Case Of Hormone-encoding Gene Overexpression Underlying A Congenital Disorder |
title_sort | fri307 gigantism due to transcriptional activation of ghrh: the first case of hormone-encoding gene overexpression underlying a congenital disorder |
topic | Neuroendocrinology & Pituitary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555338/ http://dx.doi.org/10.1210/jendso/bvad114.1242 |
work_keys_str_mv | AT hattoriatsushi fri307gigantismduetotranscriptionalactivationofghrhthefirstcaseofhormoneencodinggeneoverexpressionunderlyingacongenitaldisorder AT katohfukuiyuko fri307gigantismduetotranscriptionalactivationofghrhthefirstcaseofhormoneencodinggeneoverexpressionunderlyingacongenitaldisorder AT zhangruogu fri307gigantismduetotranscriptionalactivationofghrhthefirstcaseofhormoneencodinggeneoverexpressionunderlyingacongenitaldisorder AT teraomiho fri307gigantismduetotranscriptionalactivationofghrhthefirstcaseofhormoneencodinggeneoverexpressionunderlyingacongenitaldisorder AT takadashuji fri307gigantismduetotranscriptionalactivationofghrhthefirstcaseofhormoneencodinggeneoverexpressionunderlyingacongenitaldisorder AT nakabayashikazuhiko fri307gigantismduetotranscriptionalactivationofghrhthefirstcaseofhormoneencodinggeneoverexpressionunderlyingacongenitaldisorder AT hatakenichiro fri307gigantismduetotranscriptionalactivationofghrhthefirstcaseofhormoneencodinggeneoverexpressionunderlyingacongenitaldisorder AT yamadayutaka fri307gigantismduetotranscriptionalactivationofghrhthefirstcaseofhormoneencodinggeneoverexpressionunderlyingacongenitaldisorder AT matsuuranobuo fri307gigantismduetotranscriptionalactivationofghrhthefirstcaseofhormoneencodinggeneoverexpressionunderlyingacongenitaldisorder AT fukamimaki fri307gigantismduetotranscriptionalactivationofghrhthefirstcaseofhormoneencodinggeneoverexpressionunderlyingacongenitaldisorder |